Skip to main content

XDx Restructuring Topped Most-Read GenomeWeb Daily News Articles Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb Daily News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Nov. 28.
1. XDx to Restructure, Cut 25 Jobs (from Nov. 24)
2. Sequenom, Collaborators Demonstrate Efficacy of Non-Invasive Prenatal Monogenic Disease Test (from Nov. 25)
3. UK Firm Smiths Seeks to Enter MRSA Molecular Dx Market; Eyes Partnerships for LATE PCR Tech (from Nov. 26)
4. PerkinElmer Becomes Corporate Sponsor for EMBL (from Nov. 24)
5. All ABI Shareholders to Receive Cash and Stock in Invitrogen Merger (from Nov. 28)
The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.